---
figid: PMC8326758__fendo-12-598008-g001
figtitle: Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and
  Related Epigenetic Mechanisms
organisms:
- NA
pmcid: PMC8326758
filename: fendo-12-598008-g001.jpg
figlink: /pmc/articles/PMC8326758/figure/f1/
number: F1
caption: The mechanisms of exogenous FGF21 action in DCM treatment. FGF21 plays an
  anti-apoptosis role in cardiomyocytes by activating PI3K/Akt2/Bcl-2/Bax/Caspase
  3 pathway and ERK1/2/p38 MAPK/AMPK pathway. FGF21 protects against oxidative stress
  by activating AMPK/Akt2/GSK3β/Fyn/Nrf2 pathway. FGF21 lowers lipid accumulation
  via activating AMPK/ACC/CPT-1 pathway and ERK1/2/PGC-1α/CPT-1 pathway in the myocardium.
  FGF21 reduces inflammation in cardiomyocytes by upregulating AMPK/PON1 signaling.
  The effect of FGF21 on the treatment of DCM is also regulated by adiponectin. PI3K,
  phosphatidylinositol-3-kinase; Akt2, protein kinase B; Bcl-2, B-cell lymphoma-2;
  Bax, Bcl-2-associated X protein; ERK1/2, extracellular signal-regulated kinase 1/2;
  p38 MAPK, mitogen-activated protein kinase 14; AMPK, adenosine 5′-monophosphate
  (AMP)-activated protein kinase; GSK3β, glycogen synthase kinase-3β; Nrf2, nuclear
  factor (erythroid-derived 2)-like 2; ACC, acetyl-CoA carboxylase; CPT-1, carnitine
  palmitoyltransferase 1; PGC-1α, peroxisome proliferator-activated receptor-γ coactivator-1α;
  PON1, paraoxonase 1; DCM, diabetic cardiomyopathy.
papertitle: The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications
  and Related Epigenetic Mechanisms.
reftext: Mengjie Xiao, et al. Front Endocrinol (Lausanne). 2021;12:598008.
year: '2021'
doi: 10.3389/fendo.2021.598008
journal_title: Frontiers in Endocrinology
journal_nlm_ta: Front Endocrinol (Lausanne)
publisher_name: Frontiers Media S.A.
keywords: FGF21 | epigenetic | diabetes | cardiovascular complications | mechanisms
automl_pathway: 0.961382
figid_alias: PMC8326758__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8326758__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8326758__fendo-12-598008-g001.html
  '@type': Dataset
  description: The mechanisms of exogenous FGF21 action in DCM treatment. FGF21 plays
    an anti-apoptosis role in cardiomyocytes by activating PI3K/Akt2/Bcl-2/Bax/Caspase
    3 pathway and ERK1/2/p38 MAPK/AMPK pathway. FGF21 protects against oxidative stress
    by activating AMPK/Akt2/GSK3β/Fyn/Nrf2 pathway. FGF21 lowers lipid accumulation
    via activating AMPK/ACC/CPT-1 pathway and ERK1/2/PGC-1α/CPT-1 pathway in the myocardium.
    FGF21 reduces inflammation in cardiomyocytes by upregulating AMPK/PON1 signaling.
    The effect of FGF21 on the treatment of DCM is also regulated by adiponectin.
    PI3K, phosphatidylinositol-3-kinase; Akt2, protein kinase B; Bcl-2, B-cell lymphoma-2;
    Bax, Bcl-2-associated X protein; ERK1/2, extracellular signal-regulated kinase
    1/2; p38 MAPK, mitogen-activated protein kinase 14; AMPK, adenosine 5′-monophosphate
    (AMP)-activated protein kinase; GSK3β, glycogen synthase kinase-3β; Nrf2, nuclear
    factor (erythroid-derived 2)-like 2; ACC, acetyl-CoA carboxylase; CPT-1, carnitine
    palmitoyltransferase 1; PGC-1α, peroxisome proliferator-activated receptor-γ coactivator-1α;
    PON1, paraoxonase 1; DCM, diabetic cardiomyopathy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT2
  - BCL2
  - BAX
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - MAPK3
  - MAPK1
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - FYN
  - ELL
  - GABPA
  - NFE2L2
  - FGF21
  - ACACA
  - BMS1
  - ACACB
  - CPT1A
  - CPT2
  - CHPT1
  - PPARGC1A
  - PON1
---
